NovaBay Pharmaceuticals, Inc.
NBY · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,293 | -$1,964 | -$3,330 | -$1,323 |
| Dep. & Amort. | $73 | $38 | $55 | $95 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4 | $0 | $0 |
| Change in WC | $74 | -$1,089 | $1,334 | $229 |
| Other Non-Cash | -$654 | $20 | $617 | $142 |
| Operating Cash Flow | -$1,800 | -$2,991 | -$1,324 | -$857 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$507 | $500 |
| Stock Issued | $0 | $0 | $614 | $0 |
| Stock Repurch. | $0 | -$174 | -$1,815 | $0 |
| Dividends Paid | -$4,815 | $0 | $0 | $0 |
| Other Fin. Act. | $3,496 | $0 | $0 | -$115 |
| Financing Cash Flow | -$1,319 | -$174 | -$1,708 | $385 |
| Forex Effect | $0 | $42 | $11,203 | $126 |
| Net Chg. in Cash | -$3,119 | -$3,123 | $8,171 | -$346 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,821 | $8,944 | $430 | $776 |
| End Cash | $2,702 | $5,821 | $8,601 | $430 |
| Free Cash Flow | -$1,800 | -$2,991 | -$1,324 | -$857 |